
The United States and the United Kingdom are reportedly set to reach an agreement on a zero-tariffs deal on pharmaceuticals.
According to a report by The Times, the deal will result in zero tariffs on pharmaceutical products imported in the U.S. from the U.K. It will also lead to an increase in the U.K. government’s spending on the National Health Service (NHS).
The report states that the agreement between the U.S. and the U.K. is expected to be announced in the coming days. The U.K. government is also said to have agreed to a reduction in the industry sales rebate on NHS drug prices.
AstraZeneca Plc.’s (AZN) shares were up 0.1% in Monday’s pre-market trade. Retail sentiment around the company trended in the ‘bullish’ territory at the time of writing. AstraZeneca is the U.K.’s largest pharmaceutical company.
Get updates to this story developing directly on Stocktwits.<
For updates and corrections, email newsroom[at]stocktwits[dot]com.<
Stay updated with all the latest Business News, including market trends, Share Market News, stock updates, taxation, IPOs, banking, finance, real estate, savings, and investments. Track daily Gold Price changes, updates on DA Hike, and the latest developments on the 8th Pay Commission. Get in-depth analysis, expert opinions, and real-time updates to make informed financial decisions. Download the Asianet News Official App from the Android Play Store and iPhone App Store to stay ahead in business.